One born every minute? 4 born every second!

  • New interactive counter designed by Stem Cell Storage Company Smart Cells reveals how many babies are born on each continent, every second, minute and hour that passes.

  • They also revealed the percentage of children under 5 who have the blood disease anaemia, had access to prenatal healthcare and had a healthcare professional attend the birth.

  • On average in Europe and Central Asia, 21 babies are born every minute.

  • In Sub-Saharan Africa 60% of children have anaemia

  • Only 86% of women in the Middle East & North Africa receive prenatal care compared to 100% of women in North America.

  • And just 58% of births in Sub-Saharan Africa are attended by skilled health staff compared to 99% in Europe and Central Asia.

An estimated 130 million* babies are born globally each year. The current estimated global population stands at over 7.7 billion** and is expected to keep rising.

But how do birth rates compare continent by continent, and what is the level of healthcare for pregnant women like globally?

Stem Cell Storage Company Smart Cells have created an interactive counter which shows how many babies are born every second, minute and hour by continent. As well as highlighting how many children under the age of 5 have anaemia.

The counter

When you open the page, the counter starts charting birth rates by continent, continuing until you close the webpage.

Sub-Saharan Africa sees the most babies born globally, there is one child born less than every second, 72 born a minute and 4,344 every hour.

The below table shows the population for each continent, CBR, and then from that the total births in that period.


East Asia & Pacific

Europe & Central Asia

Latin America & Caribbean

Middle East & North Africa

North America

South Asia

Sub-Saharan Africa

















Total Births









The Crude Birth Rate (CBR, number of live births per 1,000 in a population in a set period) compared to population shows whilst East Asian & the Pacific has the highest population its CBR is lower than both the Middle East &North African and Sub-Saharan Africa.

The below table shows births per second, minute and hour for each continent.



East Asia & Pacific

Europe & Central Asia

Latin America & Caribbean

Middle East & North Africa

North America

South Asia

Sub-Saharan Africa


























Only East Asia & Pacific, South Asia and Sub-Saharan Africa have a birth every second, North America has the lowest number of births as well as the lowest population of the continents. Every hour over 4,000 babies are born in South Asia and over 4,300 in Subsaharan Africa.

The below table shows the percentage of children under the age of 5 have anaemia, the percentage of pregnant women receiving prenatal care and the percentage of women whose births are attended by skilled health staff.


East Asia & Pacific

Europe & Central Asia

Latin America & Caribbean

Middle East & North Africa

North America

South Asia

Sub-Saharan Africa

Children with Anemia








Prenatal care








Birth attended by skilled staff









Anaemia is the most common of all blood disorders, and it affects almost one-third of the world’s population, most commonly found in children under the age of five.

Millions of pregnant women globally don’t have access to suitable prenatal care. Only 50%*** of women globally receive the recommended amount of care during pregnancy. Additionally, not every birth is attended by skilled health staff. An estimated 303,000 mothers and 2.5 million newborns in the first month of life in 2017 died, partly due to inadequate care during delivery.****

Shamshad Ahmed, CEO at Smart Cells, commented:

“Our research has shown that there are huge variations in the number of births globally, some countries seeing significantly less than others and the disparities in healthcare for pregnant women from those in the developed world to those from less developed nations. We show that Anaemia, which is the most common of all blood disorders and affects almost one-third of the world’s population is significantly more prevalent in certain continents compared to others, with children in the poorer regions across Asia and Africa most affected. Stem cell therapy, however, can help alleviate the symptoms of anaemia, by boosting the production of healthy red blood cells. Additionally, our research highlighted, there are still women who do not have access to or only limited access to prenatal health care, whilst even more, do not have a skilled member of health staff in attendance for the birth. Maternal healthcare is still inadequate in many nations.

Advances in medicine, sanitation, and food production, has helped population numbers increase faster from the 1900s onwards. However, experts do believe population growth will peak in the next 100 years. Recently the negative effect that higher population has on our planet has been highlighted, by campaigners, celebrities and the Royal Family. Experts believe limiting your family to only one or two children can help stabilise population growth to a level that won’t put as much strain on our planets natural resources.***** It’s hard to imagine the global population and births until you see it in numbers.”

You can find the Global Birth Rate counter here:

Videos via YouTube: and

The Anaphylaxis Campaign is the only UK charity operating solely for the people at risk from severe allergic reactions

The Anaphylaxis Campaign is the only UK charity operating solely for the people at risk from severe allergic reactions We provide information & support to enable people living with anaphylaxis to be more confident and in control of their lives.
The aim of the charity is to create a safe environment for all people with allergies by working with and educating the food industry, schools, pre-schools, colleges, health professionals and other key audiences. As part of what we offer, we provide a National helpline service for anyone wanting advice or support over the phone, over email or via social media. The helpline is open Monday to Friday from 9am-5pm and is made up of in-house specialist advisors who can answer questions and give advice on everything from allergy care to food labelling.
With over 2 million people living with food allergy, we asked our helpline team about the type of questions they receive on a daily basis….

  1. In your time at the charity have you seen an increase in calls to the helpline? If so, can you estimate the percentage for this this time?

“Yes, the number of enquiries made to the helpline is increasing year on year and so far this year we have received over 2000 calls, emails and social media enquiries. We had a dramatic increase in enquiries between 2016 to 2017 when we extended the helpline to social media messages, which was really well received”.


  1. Are there any questions that are continually being asked by people that contact you?

“It really depends on the time of the year, we can certainly spot trends. Around festive periods we get lots of questions about free-from products, in the summer there are lots of questions about travelling with an allergy or managing a venom allergy and in September we get a lot of school related questions”.


  1. Do you find that it is mainly parents calling for information for their children or individuals ring up about their own allergens?

“It is mainly parents and carers who have questions around the management of their child’s allergy, however we do get lot of allergic adults calling us too. Occasionally we receive enquires from teenagers and young adults, however they do tend to connect with us more via social media”.


  1. The helpline offers support via telephone, email and social media, which channel do you find is most popular?

“The introduction of social media messages created a shift in the way people contact us, especially young people but calls currently remain the most popular form of contact (47%), followed by emails (43%) and then social media messages (10%)”.


  1. Do you receive questions from outside the UK? If so, how many did you receivelast year and has this increasedfrom previous years?

“In 2018 we received 45 enquires from overseas and in 2017 we received 76 from overseas, so the amount has decreased slightly over the last few years. We find these are mostly people travelling to the UK who are after help, support or advice while they travel”.



If you have an allergy or care for some who does or if you work in education, healthcare or the food industry

and need information or support on allergies, you can call, email or message our helpline team by:


Phone: 01252 542029


Or via our Facebook page @Anaphylaxiscampaign

IDTechEx Analysts Share 5 Key Lessons from Healthcare Sensor Innovations 2019

Healthcare Sensor Innovations 2019 was a conference and table-top exhibition organized by IDTechEx, a market intelligence and events company. The event was held over 25-26 September 2019 in Cambridge, United Kingdom and attracted over 185 delegates from over 23 countries. Forty speakers from the healthcare, electronics, and materials industries shared their progress in wearables and sensors for point-of-care diagnostics and continuous monitoring. IDTechEx technology analysts Dr Nadia Tsao and Dr Ivan De Backer explore the technology developments and market trends presented at Healthcare Sensor Innovations 2019 (


Printed electronics are opening new doors for sensor devices

Printed electronics, and the benefits of their integration into healthcare devices, were a central theme at Healthcare Sensor Innovations 2019. Electronics can be printed on a variety of materials and surfaces including plastic, textile, paper and foil to generate robust and durable medical device components. This enables electronic functionality to be added to places which are not possible using rigid electronics. A crucial advantage of printed electronics, which was mentioned repeatedly throughout the conference, is that they enable the development of new form factors for medical sensors. These sensors now can be flexible, foldable, stretchable and transparent, which considerably widens their applications.


Wearable sensors bring increased sensitivity to patient tracking…

The medical industry currently represents the biggest opportunity for wearable technology. IDTechEx forecasts that the market for medical wearables over the coming five years will grow faster than the overall wearable technology market. There are various uses for wearables in the healthcare space, including diagnostics, monitoring, and consumer health. Wearables enable remote patient monitoring (RPM), which is becoming a valuable tool in increasing convenience to patients and reducing treatment costs. In addition to providing more sensitive methods to tracking patients and disease progression, these technology innovations will keep people in their homes for longer and help reduce burdens on the healthcare system.


…but the value of data must be understood first

Healthcare Sensor Innovations 2019 keynote speakers highlighted the importance of not only developing new healthcare sensors, but also in creating new ways to analyze and interpret the streams of data being collected. While there is a swathe of health-related parameters that can be measured using medical wearables, the value of each measurement must be weighed against the increased complexity it may bring to the patient or clinical workflow. Moreover, the data measured must be verified and validated before implementation of the technology on a mass scale. Finally, care must be taken in the misinterpretation of data that can lead to incorrect diagnostics and treatments.


Patient comfort and willingness are key to success

The need for sensors in wearables to be stretchable was unanimously acknowledged among the speakers and exhibitors at Healthcare Sensor Innovations 2019. Patient comfort must be prioritized and thus sensor systems must be unobtrusive to the patient. Hence, wearable sensors should come in flexible and thin form factors, particularly in the case of electronic skin patches and smart clothing. But even when patients declare that they are willing to use a technology, adherence to their monitoring may still be low. Thus, devices must be easy to use and familiar to the patient for maximum efficacy.


Sensors play key role in helping patients with chronic diseases

Innovations in wearables and sensors have the potential to bring much needed help to patients suffering from chronic diseases. Throughout the 2 days of Healthcare Sensor Innovations 2019, speakers discussed their work in bringing sensors to better quantify disease symptoms in patients and help predict and prevent acute episodes. The former is particularly important in disease areas such as amyotrophic lateral sclerosis and rheumatoid arthritis, where metrics of disease progression rely on patient perception, rather than an objective measurement. Moreover, in highly personalized conditions such as asthma and irritable bowel syndrome, sensors can help patients to understand their personal triggers and prevent future episodes.


The next Healthcare Sensor Innovations conference will be held 16 – 19 March 2020 in San Jose, CA, USA. To find out more about Healthcare Sensor Innovations and the opportunities for flexible, connected, and miniaturized electronics in healthcare, please visit


IDTechEx guides your strategic business decisions through its Research, Consultancy and Event products, helping you profit from emerging technologies. For more information on IDTechEx Research and Consultancy contact or visit

Our Vision Beyond 2020: Many Partners, One Voice

A decade of partnership Ten years ago, the Neglected Tropical Disease NGO Network (NNN) was established to enhance the contribution of NGOs towards a vision of a world free of neglected tropical diseases. The NNN is a dynamic and diverse network bringing together over 80 NGO members worldwide to speak with a unified NGO voice. The network has grown into an established forum for collaboration, developing a community of practice and partnerships to overcome barriers to beating NTDs.

Over the last decade, NNN members have worked together to make significant contributions to global progress on combating NTDs. The NNN successfully championed the inclusion of an indicator on NTDs in the SDG framework. In 2016 the NNN launched its BEST (Behaviour, Environment, Social inclusion, Treatment & Care) framework, which sets out the NTD community’s commitment to forging new partnerships and working across sectors to ensure equity and inclusion in efforts needed to reach control, elimination, and eradication targets for NTDs. In 2019, the NNN’s WASH working group partnered with the World Health Organization to publish a collaboration toolkit, WASH and health working together: A ‘how-to’ guide for Neglected Tropical Disease Programmes. It provides NTD programme managers and partners with practical guidance to build and deliver multi-sectoral partnerships and action.

2020: Year of action on NTDs

2020 is a defining year for the next, bolder phase of efforts to combat NTDs. During the opening plenary session, Dr. Mwele Malecela, WHO NTD Director stated “I was asked to speak today about WHO’s vision post-2020…but my main aim today is to talk of our shared vision. We would not be where we are today and would not have made the significant progress we have without the spirit of collaboration which I believe defines our NTD community.” In 2020, NNN members will champion a new ambitious WHO NTD Roadmap 2021 – 2030, underpinned by cross-cutting approaches.

Our commitment

This year the NNN launched two statements on sustainability and our commitment to safety, highlighting its alignment with the global health and development agenda. In the year ahead, the NNN community commits to expanding and strengthening existing and new partnerships between NTDs and across sectors inclusive of WASH, disability, education, one health and humanitarian aid. Through cross-cutting approaches codified through the BEST framework, we will contribute to strengthening health systems, ensure the sustainability of control and elimination efforts and amplify the voices of people affected by NTDs and those working on the front lines.

About the Neglected Tropical Diseases NGO Network

With over 70 members worldwide, the NNN is a forum for partners working together to improve health for the world’s poorest populations and build a brighter future for all people.

The NNN is built on partnerships: across diseases, between cross-cutting issues and with governments.

© The Leprosy Mission by kind permission of Tom Bradley

Flow unveils chatbot therapist to combat depression

A chatbot therapist to treat depression has launched as recent figures show that NHS patients seeking help with their mental health are waiting more than eight weeks to see a doctor after their first appointment.1 The chatbot therapist was developed by medical device company Flow, which in June launched a brain stimulation headset treatment for depression, the first and only medically approved at-home treatment of its kind in the UK and EU.

The chatbot therapist, called Flow, engages users with daily chat conversations and offers self-help techniques, mood tracking, curated videos, meditation and mental exercises. It helps users to learn why sleep, exercise, nutrition and meditation are the main pillars in recovering from depression – and gathers mood data to offer a personalised response modelled on behavioural therapy.

“I feel like I have a buddy who’s just chatting with me, no judgement, and forcing me to pace myself.”

Flow user

Watch Flow in action

Available to download free on iOS, the chatbot therapist is based on the latest psychology and neuroscience research, and was developed by clinical psychologists and machine learning experts. An Android version will be available in October 2019.

Nearly one in four adults in the UK are affected by a mental illness.2 Suicide is the most common cause of death for men aged 20-49 years in England and Wales.3 The economic costs of mental illness in England is estimated at £105.2 billion annually.4 And one in three work sickness notes handed out by GPs are for mental health reasons, including depression.5

“Accessibility and early intervention in depression is crucial,” says Daniel Mansson, Clinical Psychologist, CEO and Co-Founder of Flow. “The ‘always-on’ source of therapy provided by Flow ensures people get the help they need as quickly as possible. Flow can provide anonymity without the fear of being judged by others. This is great as some people feel anxious when it comes to talking about their depression to another human.”

To maximise the chance of recovery, Flow can be used in conjunction with the Flow brain stimulation headset. Randomised controlled trials published in the New England Journal of Medicine and the British Journal of Psychiatry show that brain stimulation, of the type used in the Flow headset, had a similar impact to antidepressants but with fewer and less-severe side effects.6,7,8 The Flow headset retails at £399 and can be purchased here.

Flow joins a growing number of mental health chatbots, including Woebot and Wysa, which are playing an increasing role in the mental health landscape. Whilst Woebot and Wysa use a cognitive behavioural approach to change the way people think, Flow has one goal: to reduce clinical depression based on well-grounded science.

Flow is starting talks with the NHS to have its brain stimulation headset available on prescription. The company recently announced an investment of £1.2 million by Khosla Ventures to roll out its offering across Europe, introduce the Flow headset to healthcare clinics in the UK, and fund clinical studies.

More than a quarter of people who die from liver disease in hospital have no previous admission in the year before their death

New data released today at the largest conference for liver clinicians reveals that around 5,200 people die from liver disease in hospital in England each year. Of these, 30% of those have not had an admission in the year before death. On admission to hospital time is of the essence in saving these seriously ill patients. 1 in 4 of those who die do not survive more than 3 days and 43% do not survive a week.

These are people with advanced liver disease and many of their lives could have been saved if they had been diagnosed earlier in primary or secondary care and had been given advice on risk factors like alcohol and management of their liver disease.

The analysis is being presented at the British Association of Liver Disease annual conference in Glasgow. The data also reveals that these deaths occur in relatively young people. 60% of these patients are under 64 years of age and that one in five are under the age of 50.

Liver disease has increased by 400% since 1970 and it’s the biggest cause of death in those aged between 35-49 years old in the UK.[1]

This new data highlights the urgent need for improvements in early detection of the disease as most patients are being diagnosed too late in an emergency setting.

Professor Matthew Cramp, president at BASL, says: “Many people with liver disease are unaware that they have it because there are usually have no symptoms in the early stages.  Too often the first a patient knows about their liver disease is when they are admitted as an emergency to hospital with life threatening complications. Even with the doctors’ best efforts some patients are so ill that their life cannot be saved.”

“It’s vital that GPs and other healthcare professionals identify those at risk so that more patients are diagnosed at an early stage.”

The research used Office for National Statistics mortality data and Hospital Episode Statistics data supplied by NHS Digital. Other alarming facts highlighted by the research:

·         29.1% of the patients who died in hospital had no previous admission in the year

·         20.8% had only one previous admission in the year before they died

·         25.3% of those who die do not survive more than 3 days in hospital

·         43% of those who die do not survive more than a week in hospital.

·         2,230 liver patients die each year in hospital in a week or less from admission, that is 43 patients per week or 6 patients every day.

·         The majority (60%) of those dying from liver disease in hospital are under the age of 64 and 20% are under the age of 50.

·         At least two-thirds of the patients who died with no previous admission in the year before death died from alcohol related liver disease

·         Patients admitted to hospitals with specialist liver services are more likely to be seen by a specialist in liver disease and be admitted to ITU

Professor Matthew Cramp, president at BASL, says: “Despite being young and very sick, many patients die from the disease without ever being seen or cared for by a specialist. Patients with life-threatening liver disease complications need to be recognised quickly when they arrive at hospital and should be seen by a specialist with knowledge of liver disease quickly and treated according to Guidelines.”

This study found that the chance of these patients being seen by a specialist (Gastroenterologist or hepatologist) and being admitted to ITU was higher if they were admitted to a hospital with specialist liver services.

Matthew Cramp adds: “Smaller hospitals should link with specialist hospitals to consult with experts or transfer patients if appropriate.”

Liver problems develop silently with no obvious symptoms in the early stages yet if caught early, the disease can be reversed through lifestyle changes.  More than 90% of liver disease is due to three main risk factors: obesity, alcohol and viral hepatitis.

Pamela Healy, Chief Executive, British Liver Trust said, “This research highlights the liver disease epidemic we are facing in the UK. While the data presented is based on England only, this is likely to reflect the situation with liver disease in Scotland, Wales and Northern Ireland.”

To coincide with the BASL conference, The British Liver Trust’s Love Your Liver roadshow is at the University of Strathclyde today offering free liver health screening and scanning.

Pamela continues: “Helping people understand how to reduce their risk of liver damage is vital to address the increase in deaths from liver disease. Although the liver is remarkably resilient, if left too late damage is often irreversible. I would urge everyone who is unable to attend the roadshow to take our online screener on our website to see if they are at risk.”

Performance at Marie Curie raises awareness of challenges accessing health & social care when supporting loved ones with terminal illnesses & life limiting conditions

An award-winning playwright will be raising awareness of the challenges supporting a family member with a terminal illness when he brings his performance to the Marie Curie Hospice, West Midlands, this October.

In ‘Fighting For Life,’ Brian Daniels explores ways older people struggle with accessing social and health care support, by letting audiences peek into the lives, heartaches and good times experienced by the true story of ‘Jim’ and ‘Joan.’

James and Joan Findlay have been married for 62 years. Joan has dementia and, with their four adult children leading busy lives elsewhere, her principal carer is her husband, James.

When James is diagnosed with motor neurone disease, the family find themselves navigating a fractured health and social care system to get their parents the help they need and to keep them together to the end.

The inspiration for the play came from the Findlay Report (published in 2006), which was written with the support of the Findlay family after the death of their parents.

By putting together their experiences and recommendations for how things could improve, the family wanted to chart the issues around caring for the elderly – particularly the most vulnerable – and help other families to get better support than they did.

It is now 13 years since the Findlay family’s experience and yet the same challenges exist for people living with complex needs at the end of life.

The play will be performed on Tuesday 8th October, 2.30 – 4pm, at the hospice on Marsh Lane, Solihull.

Suzanne McArthur, Allied Healthcare Professional and Community Engagement Lead, said:

“We are excited to be hosting such a thought-provoking play on a subject many of us are likely to face in our lifetime. The play highlights the struggles one family faces in dealing with the challenges of supporting a loved one who is terminally ill through its unique approach to story-telling.

“Here at the Marie Curie Hospice, West Midlands, we offer the reassurance of specialist care and support, in a friendly, welcoming environment, for people living with a terminal illness and their loved ones – whether someone is staying in the hospice, being supported at home or just dropping into one of our support groups or cafés.”

The performance will be followed by afternoon tea and a panel discussion. Dr. Helen Findlay, one of James and Joan’s children who is a member of Marie Curie’s Expert Voice Panel, will be joined by local professionals and service users, who will discuss themes raised in the play including the future of end of life care.

For tickets or more information, please contact:

Kaia Health Announces 8 Million in Funding Led by Optum Ventures

Kaia Health, a digital therapeutics company, today announced an $8 million funding round, the second significant investment this year. The infusion of capital is led by Optum Ventures.

Kaia Health has developed a smartphone-based approach for managing a range of chronic conditions, with its leading product focused on musculoskeletal disorders (MSK) such as chronic back pain. The investment by Optum Ventures helps Kaia Health address the rising costs of treating MSK-related conditions, the difficulty patients have in accessing gold-standard treatment, and the need for innovative, scaleable and cost-effective technology solutions to confront this issue.

Kaia Health’s world-leading 2D motion tracking technology enables users to get real-time feedback on their exercise performance using their smartphone’s camera, which, when taken together with the platform’s psychological and eduction support, has been proven to outperform conventional therapy.

“The investment from Optum Ventures will allow us to explore integration opportunities throughout the complete patient treatment journey,” said Konstantin Mehl, Founder and CEO of Kaia Health. “We are proud to partner with Optum Ventures, a company at the forefront of improving healthcare.”

Optum Ventures’ investment will be used to accelerate sales growth in the U.S. healthcare market, extend the platform into other chronic indications and expand the supporting clinical evidence base.

“Kaia Health has taken a technology-led approach to create digital therapeutics that will make treatment more accessible to patients who need it,” said Heather Roxborough, Partner at Optum Ventures. “We believe Kaia Health’s digital therapeutic solutions will benefit those suffering from MSK disorders and are excited about its application in other indications.”

With three peer-reviewed clinical studies, including a randomized controlled trial recently published in NPJ Digital Medicine, Kaia Health has demonstrated its commitment to creating validated digital therapeutics and has additional clinical studies ongoing in the United States.

Project at Ulster University to develop new technology to combat heart failure receives Heart Research UK grant

A project at Ulster University aiming to develop a better way of powering mechanical heart pumps used to treat heart failure has received a grant of almost £250,000 from national charity Heart Research UK.

The Novel and Emerging Technologies (NET) grant has been awarded to Prof Omar Escalona and his team at Ulster University and at Craigavon Area Hospital (SHSCT) to develop an innovative wireless power solution for heart pumps used to support patients with heart failure.

Heart failure occurs when the heart is not able to pump enough blood around the body. Around 920,000 people in the UK are currently living with heart failure, and one-fifth of patients die within one year of diagnosis.

Whilst the only effective solution is a transplant, mechanical pumps known as left ventricular assist devices (LVADs) can support a failing heart.

LVADs significantly improve survival and quality of life in patients with advanced heart failure, and are increasingly used as a temporary bridge to transplantation or as permanent therapy.

However, the electric power is supplied to LVADs via a driveline cable through the skin which leads to a high incidence of infection.

The infection problem has prompted the development of wireless power transmission solutions for LVADs. However, the implanted energy receiver coil of these wireless systems causes heating in the tissues, leading to local skin and tissue damage.

Professor Escalona and his team are developing a new wireless system which transmits electromagnetic wave pulses of energy in a new way, meaning tissues can cool down between energy transmission pulses.

If successful, this could improve clinical outcomes and quality of life for heart failure patients and may accelerate a more widespread use of LVADs in the treatment of heart failure.

Prof Omar Escalona said: “This is an incredibly exciting project that really has the potential to improve outcomes for patients with heart failure who are a awaiting a heart transplant or who have been prescribed LVAD therapy for their heart condition.

“By reducing the risk of infection and local tissue damage, we hope to make LVADs a more viable option for patients, and see an increase in both their uptake and their therapeutic benefit.

“We are very grateful to Heart Research UK for appreciating our work at Ulster and supporting this research, and are looking forward to initiating the research project.

Kate Bratt-Farrar, Chief Executive at Heart Research UK, said: “We are delighted to be supporting Prof Escalona’s research, which has the potential to have a big impact on the lives of those living with heart failure.

“Our NET grants are all about backing new and innovative developments in medical technology that can quickly and efficiently translate into real patient benefits.

“The dedication we see from UK researchers is both encouraging and impressive and we at Heart Research UK are proud to be part of it.”

The £248,436 grant was awarded to Ulster University as part of Heart Research UK’s annual awards for research into the prevention, treatment and cure of heart disease.

In the last year, Heart Research UK has awarded more than £1.3 million in grants for medical research projects across the UK. To date, the charity has invested more than £25 million in medical research via its grants programme.

Healthcare Meets Electronics: Event Assesses the Opportunities

Registrations for the inaugural Healthcare Sensors Innovation event in Cambridge on 25-26 September is exceeding all expectations and nears venue capacity. The event is successfully bringing together the linchpins of the healthcare industry with the electronics industry to explore the opportunity in two specific areas: point of care diagnostics and continuous monitoring.

The event addresses the needs and opportunities for faster diagnosis, remote monitoring and treatment and the opportunity for new revenue streams, alongside the progress of the enabling technologies including biosensors, flexible electronics, low power electronics and connectivity.

Attendees include pillars of the healthcare industry such as AstraZeneca, GSK, Baxter Healthcare, Boston Scientific, Smith & Nephew, W.L. Gore and LifeScan.

Uniquely these organizations are brought together with those in electronics and electronics materials, including Analog Devices, Philips, STMicroelectronics, Samsung, Sun Chemical, Maxim Integrated, Molex, Nissha, Henkel, and many others.

Nadia Tsao, Senior Technology Analyst who runs the Life Sciences research practice at IDTechEx, reports, “The success of this event is down to its focus on two core growth areas: continuous monitoring and point-of-care diagnostics. With aging populations, shortage of medical staff, and the need to rapidly diagnose and treat based on accurate measurement data, this event focuses on pragmatic applications of technology innovations that are occurring now, such as the $7.5 billion electronic skin patches market.”

The event will be held at Clare College, part of the University of Cambridge. Cambridge was selected for the event location due to the large number of healthcare and pharmaceutical companies in the area and many world leaders in electronics have significant development bases there.

Healthcare Sensor Innovations is market led and analyst driven, meaning that industry analysts IDTechEx have devised the event based on showcasing market challenges and needs and how they are being addressed. Learn more and register now at

IDTechEx guides your strategic business decisions through its Research, Consultancy and Event products, helping you profit from emerging technologies. For more information on IDTechEx Research and Consultancy contact or visit